Pivotal Study of the Velocity™ pAVF System
NCT: NCT07153939 · RECRUITING
Brief Summary
This study will evaluate the Velocity Percutaneous Arteriovenous Fistula (pAVF) System, a new minimally invasive method for creating dialysis access. People with kidney failure often require dialysis, which depends on having a reliable arteriovenous fistula (AVF). Traditionally, AVFs are created with surgery, but surgery can involve incisions, longer recovery, and sometimes additional procedures before the AVF can be used. The Velocity System is designed to create an AVF through a small puncture in the skin using a catheter-based approach, without open surgery. This pivotal study will assess how safe the procedure is and how well it works for patients who need dialysis. The study will take place at multiple centers in the United States and will enroll adults with kidney failure who are candidates for fistula creation. Participants will undergo the Velocity procedure and then be followed closely with exams, ultrasounds, and dialysis assessments for up to five years. Taking part is voluntary. Patients may benefit from a less invasive approach to dialysis access, but the main goal is to collect information that could improve future care for people with kidney failure.
Frequently Asked Questions
What is Pivotal Study of the Velocity™ pAVF System?
Pivotal Study of the Velocity™ pAVF System is a clinical trial registered under NCT07153939. Current status: RECRUITING.
What is the status of NCT07153939?
The current status of NCT07153939 (Pivotal Study of the Velocity™ pAVF System) is: RECRUITING.
When did Pivotal Study of the Velocity™ pAVF System start?
Pivotal Study of the Velocity™ pAVF System started on 2025-10-21.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.